Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-167-9 | CAS number: 4696-57-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- not stated
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study well documented, meets generally accepted scientific principles. Minor deviations: (i) The observation period was 1 day instead of 14 days
Data source
Reference
- Reference Type:
- publication
- Title:
- Short-term toxicity (one- and ten-day gavage) of barium chloride in male and female rats
- Author:
- Borzelleca, J.F. et al.
- Year:
- 1 988
- Bibliographic source:
- Journal of the American College of Toxicology Vol. 7 Nr. 5: 675-685
- Report date:
- 1988
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- adpoted: 24 Feb. 1987
- Deviations:
- yes
- Remarks:
- observation period was 1 day instead of 14 days
- Principles of method if other than guideline:
- one-day exposure: concentrations 30, 100 and 300 mg/kg bw. (0.75 - 1.5 % BaCl2 solutions). 10 males and 10 femals per dose level, observation period 1 day.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Barium chloride
- EC Number:
- 233-788-1
- EC Name:
- Barium chloride
- Cas Number:
- 10361-37-2
- Molecular formula:
- BaCl2
- IUPAC Name:
- barium dichloride
- Test material form:
- solid: crystalline
- Details on test material:
- - Name of test material (as cited in study report): Barium chloride (BaCl2)
- Analytical purity: >99 % (Aldrich Chemical Company)
- Lot No.: 20245L
No further significant information on test material was stated.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Crj: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Wilmington, MA
- Age at study initiation: 22-30 days of age
- Weight at study initiation: 100-125 g
- Fasting period before study: Rats were deprived of food but had free access to water for 16-18 hr before being dosed.
- Housing: The rats were housed individually in stainless steel wire-bottomed suspended cages.
- Diet (ad libitum): Purina Rodent Chow No. 5001 (Ralston Purina Co., St. Louis, MO)
- Water (ad libitum)
- Acclimation period: Quarantined for 1 week before initiation of the studies
ENVIRONMENTAL CONDITIONS
- Temperature: 21 to 24 °C
- Humidity: 30-70%
- Photoperiod (hrs dark / hrs light): 12/12
The rats within any exposure level were caged vertically to minimize light, temperature, and airflow differences between exposure groups.
No further significant information on test animals were stated.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- 10 males and 10 femals per group
Vehicle controls received deionised water at a dose of 20.0 ml/kg body weight
MAXIMUM DOSE VOLUME APPLIED: up to 20.0 ml/kg body weight.
No further details on oral exposure was given. - Doses:
- 30 mg/kg bw., 100 mg/kg bw., 300 mg/kg bw. BaCl2 solution
- No. of animals per sex per dose:
- 10 males/10 females
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 1 day
ONE-DAY EXPSOURE STUDY
Frequency of observations and weighing: Animals were observed continuously for approx. 5 hr after dosing. Body weights were determined initially (day 1) and at termination of the study (24 hr after dosing).
Necropsy of survivors performed: At the termination of the study animals were killed with ether. Gross pathological examination was performed, followed by the removal and weighing of selected organs (brain, liver, spleen, lungs, thymus, kidneys, and testes or ovaries). All tissues were preserved in 10 % neutral buffered formalin. Histopathological evaluation was performed on liver, kidney, and heart tissue.
Other examinations performed: Urinalysis and various hematological and clinical chemistry parameters were determined.
Hematology: Determination of leukocyte, erythrocyte, platelet number, microhematocrits, prothrombin times and plasma fibrinogen levels; hemoglobin assyed as cyanomethemoglobin; Evaluation of leukocyte differentials
Serum chemistry: Serum ion concentrations were determined. Serum chemistry included SGPT (ALT), SGOT (AST), ALP, BUN, protein, glucose, cholesterol, bilirubin, creatinine, calcium phosphorous, albumin, and chloride.
No further significant information on study design. - Statistics:
- All data were subjected to an analysis of variance and test for homogeneity and a Dunnett`s t-test. Nonhomogeneous data were subjected to a Wilcoxon Rank Sum Test. Those values that differed from the vehicle group at P≤ 0.05 were considered significant. The acute oral LD50 values were calculated using the method of Finney.
Results and discussion
- Preliminary study:
- not applicable
Effect levelsopen allclose all
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 100 - < 300 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: calculation of 95% CL is not possible
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 100 - < 300 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: calculation of 95% CL is not possible
- Mortality:
- No deaths occured at the two lower doses. However, at 300 mg/kg bw., 8 of 10 males (80%) and 7 of 10 females (70%) died within 24 hr.
- Clinical signs:
- other: not stated
- Gross pathology:
- Changes observed at necropsy in a majority of male animals at the 300 mg/kg dose only included an ocular discharge, fluid in the trachea and darkened liver. Inflammation of the small and large intestines was seen in both sexes at 300 mg/kg.
- Other findings:
- Organ weights: At 30 and 100 mg/kg bw. BaCl2, there were no significant differences from vehicle control in males. In females, the lungs/brain weight, and ovaries/brain weight ratios were significantly lower at 30 mg/kg bw.. At 300 mg/kg bw., both sexes exhibited significantly lower liver/brain weight ratios, and high kidney/body weight ratios. In males only, liver weight was significantly reduced at the highest dose.
Clinical chemistry: There were no significant differences at 300 mg/kg bw in either males or females. Increases seen in SGPT (ALT), SGOT (AST), 5'-nucleotidase and phosphorous at 30 and/or 100 mg/kg bw were not dose related.
Hematology: Hematological values exhibited no significant differences from control in either sex at dosage levels of 30 and 300 mg/kg bw.. There were elevations in hemoglobin and hematocrit in males receiving 100 mg/kg bw.. Coagulation data and differential cell counts indicated no significant differences from control in either sex at any of the dosage levels.
Any other information on results incl. tables
High mortality occurred up to 80% at the highest dose level of 300 mg/kg bw whereas no mortality occurred at dose levels of 30 and 100 mg/kg bw. Due to this no exact calculation of the LD50 was performed. It could be concluded that the LD50 of BaCl2 is > 100 and < 300 mg/kg bw. Therefore, a calculation of a confidence interval is not possible.
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category III
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- According to the test design choosen in this study, it can be concluded that the LD50 of BaCl2 is >100 mg/kg bw but <300 mg/kg bw. According to the test result the substance has to be classified as harmful im swallowed (Xn; R22) due to the fact that high mortality was observed at dose levels of > 200 mg/kg bw (accroding to 67/548/EEC) and toxic category III (LD50 >50 and < 300 mg/kg bw.) according to GHS.
- Executive summary:
The results indicated that LD50 of Ba2+ is >66 mg/kg bw. and <198 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.